Barclays Issues Pessimistic Forecast for Nutrien (NYSE:NTR) Stock Price

Nutrien (NYSE:NTRGet Free Report) had its target price dropped by stock analysts at Barclays from $85.00 to $81.00 in a research report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price target would suggest a potential upside of 18.81% from the stock’s previous close.

A number of other brokerages also recently issued reports on NTR. Scotiabank upgraded shares of Nutrien from a “sector perform” rating to a “sector outperform” rating and set a $80.00 price objective on the stock in a research note on Tuesday, June 30th. Wall Street Zen lowered shares of Nutrien from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Oppenheimer dropped their price target on Nutrien from $82.00 to $80.00 and set an “outperform” rating for the company in a research note on Thursday. Raymond James Financial raised Nutrien from a “market perform” rating to an “outperform” rating and upped their price objective for the company from $74.00 to $90.00 in a research note on Tuesday, May 5th. Finally, Berenberg Bank set a $65.00 price objective on shares of Nutrien and gave the stock a “hold” rating in a research note on Wednesday, June 10th. Fifteen research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $81.94.

View Our Latest Research Report on Nutrien

Nutrien Trading Up 0.1%

Shares of Nutrien stock opened at $68.18 on Monday. The company has a market capitalization of $32.61 billion, a price-to-earnings ratio of 13.89, a P/E/G ratio of 0.67 and a beta of 0.62. The business has a fifty day simple moving average of $66.52 and a two-hundred day simple moving average of $70.09. Nutrien has a 1 year low of $53.03 and a 1 year high of $85.36. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.24 and a quick ratio of 0.59.

Nutrien (NYSE:NTRGet Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.03. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.30 billion. During the same period last year, the business posted $0.11 earnings per share. The business’s revenue for the quarter was up 18.5% compared to the same quarter last year. Research analysts forecast that Nutrien will post 5.08 EPS for the current year.

Institutional Trading of Nutrien

Several large investors have recently made changes to their positions in NTR. Guggenheim Capital LLC increased its position in Nutrien by 2.2% in the 4th quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock valued at $409,000 after buying an additional 145 shares in the last quarter. Minot DeBlois Advisors LLC boosted its holdings in Nutrien by 1.8% in the fourth quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock worth $557,000 after acquiring an additional 164 shares in the last quarter. Banque Cantonale Vaudoise grew its stake in Nutrien by 15.9% in the first quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock valued at $90,000 after acquiring an additional 164 shares during the period. Gould Asset Management LLC CA grew its stake in Nutrien by 4.4% in the first quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company’s stock valued at $297,000 after acquiring an additional 165 shares during the period. Finally, EverSource Wealth Advisors LLC increased its holdings in shares of Nutrien by 21.8% during the fourth quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company’s stock valued at $61,000 after acquiring an additional 176 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Further Reading

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.